Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pre-Phase III approval possible? EMA's faster adaptive licensing for drugs ready for testing

This article was originally published in SRA

Executive Summary

The adaptive drug licensing procedure that the European Medicines Agency had announced it was contemplating as far back as early 2011 is finally ready for use by companies that wish to test the procedure, Guido Rasi, the EMA's executive director has told Scrip Regulatory Affairs1.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS117047

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel